Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)
Clinical trial NCT01264770 · TERMINATED
Trial details
- NCT number
- NCT01264770
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-10-01
- Enrollment
- 644
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.